U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 9231 - 9240 of 13501 results

Status:
Investigational
Source:
NCT00923195: Phase 2 Interventional Completed Melanoma
(2008)
Source URL:

Class:
PROTEIN

Ovemotide, a melanoma peptide vaccine that was investigated as an antineoplastic agent. Information about the current use of this compound is not available.
Status:
Investigational
Source:
Biomed Pharmacother. Sep 2013;67(7):659-63.: Not Applicable Human clinical trial Completed Dry Eye Syndromes
Source URL:

Class:
PROTEIN

Eledoisin is an endecapeptide tachykinin receptor ligand. Originally it was isolated from salivary glands of Mediterranean octopod, Eledone moschata. Eledoisin is a powerful vasodilator and hypotensive agent in most animal species.
Status:
Investigational
Source:
NCT00040573: Phase 1/Phase 2 Interventional Completed Glioma
(2002)
Source URL:

Class:
PROTEIN

Chlorotoxin I-131 is a synthetic version of a neurotoxin investigated in clinical trials for treating brain cancer. Chlorotoxin was originally isolated from the venom of the Israeli scorpion Leiurus quinquestriatus, and has potential as a tumor imaging agent based on its selective binding to tumor cells. Molecular targets for Chlorotoxin include voltage-gated chloride channels (GCC), calcium-dependent phospholipid-binding protein Annexin-2, and the inducible extracellular enzyme Matrix Metalloproteinase-2 (MMP-2). Chlorotoxin reduced the migration ability of glioma cells through tight extracellular spaces in the brain tissue by inhibition of the MMP2 because this prevented the cells from shrinking and releasing from the extracellular matrix. Chlorotoxin is a small 36-amino-acid peptide that selectively binds to glioma cells but not normal brain parenchyma. The synthetic version of this peptide has been manufactured and covalently linked to iodine 131 as a means of targeting radiation to tumor cells in the treatment of brain cancer.
nucleic acid
Status:
Investigational
Source:
INN:agazisiran [INN]
Source URL:

Class:
NUCLEIC ACID

nucleic acid
Status:
Investigational
Source:
INN:vortosiran [INN]
Source URL:

Class:
NUCLEIC ACID

Showing 9231 - 9240 of 13501 results